​​​​​​​The Order of the Minister of Health “On Amendments and Additions to the Rules for Certification of Pharmaceutical Products” has been registered with the Ministry of Justice of the Republic of Uzbekistan (Registration No. 3386-2 dated December 25, 2025).

As part of the implementation of the Action Plan for the 2024–2025 National Program aimed at executing the National Strategy to Combat Drug Abuse and Drug-Related Crime in the Republic of Uzbekistan, the results of 2025 summarized by the Committee for Drug Control demonstrated a fundamental renewal of approaches in this area. The digitalization of control mechanisms, strengthening of licensing requirements, and implementation of preventive measures at the regional level indicate the formation of a systemati

According to the results of quality control and stability testing conducted by the manufacturer, a deviation from the established specifications was identified in batch C2501976 of the medicinal product “Telsartan H 80 mg / 12.5 mg”, specifically with regard to the content of the active substance hydrochlorothiazide. This deviation has been assessed as a quality non-conformity.

2026 yilning 23-27 fevral kunlari Farmatsevtika mahsulotlari xavfsizligi markazi USP bilan hamkorlikda hamda ICH ko‘magida "Klinik tadqiqotlarda shaffoflik, xavfsizlik va ilmiy qat’iylikni oshirishda xalqaro uyg‘unlashgan yondashuvlardan foydalanish" mavzusida seminar trening o'tkazishni rejalashtirmoqda.

2025 yil davomida Farmakopeya qo‘mitasi huzuridagi Ilmiy va ekspertlar kengashi tomonidan dori vositalari muomalasini tartibga solish bo‘yicha izchil ishlar amalga oshirildi.

O‘zbekiston Respublikasi Рrеzidеntining 2024-yil 23-yanvardagi “Farmatsevtika sohasini tartibga solish bo‘yicha qo‘shimcha сhога-tadbirlаr to‘g‘risida” PF-20-son Fаrmоnining 2-ilovasi 4-bandi “v”-kichik bandiga muvofiq, 2025 yil 1 yanvarga qadar — farmatsevtika mahsulotlarini chakana sotish bilan shug‘ullanuvchi tarmoqli dorixonalar, 2026 yil 1 yanvarga qadar — boshqa dorixonalar Zarur farmatsevtika amaliyoti (GPP) milliy talablariga muvofiq majburiy sertifikatlashtirilishi belgilangan.

Farmatsevtika sohasida litsenziyalash va davlat nazorati tizimining barqaror ishlashi bozor ishtirokchilari faoliyatida qonuniylikni ta’minlash, aholiga ko‘rsatilayotgan farmatsevtika xizmatlari sifatini saqlash hamda xavf-xatarlarni barvaqt aniqlashda muhim ahamiyat kasb etadi. 2025 yil ushbu yo‘nalishda amalga oshirilgan ishlar ko‘lami va natijalari bilan ajralib turdi.

Dori vositalarining noxush ta’sirlarini aniqlash va xavf-xatarlarni boshqarish bugungi kunda sog‘liqni saqlash tizimining eng mas’uliyatli yo‘nalishlaridan biri hisoblanadi.

Yana bir mazmunli, masʼuliyatli va samarali yil — 2025 yil ham o‘z yakuniga yetmoqda. Yangi yil ostonasida turib, avvalo, har biringizni ushbu yil davomida ko‘rsatgan fidokorona mehnatingiz, kasbiy sadoqatingiz va yuksak masʼuliyatingiz uchun samimiy minnatdorlik bilan tabriklayman.

Sog‘liqni saqlash tizimida tibbiy buyumlar va tibbiy texnikaning sifati hamda xavfsizligi — bu faqat texnik jarayon emas, balki bevosita inson hayoti va tibbiy xizmat sifati bilan bog‘liq strategik yo‘nalishdir